Keith Lamont Cummings - 13 Jun 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Chief Financial Officer
Signature: /s/ Mike Ouimette, attorney-in-fact
Issuer symbol: PLRX
Transactions as of: 13 Jun 2023
Net transactions value: +$63,960
Form type: 4
Filing time: 14 Jun 2023, 18:14:27 UTC
Previous filing: 12 Jun 2023
Next filing: 18 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLRX	Common Stock	Options Exercise	$63,960	+30,750	+20%	$2.08^*	185,020	13 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (Right to Buy)	Options Exercise	$0	-30,750	-24%	$0.000000	97,047	13 Jun 2023	Common Stock	30,750	$2.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vested in substantially equal monthly installments thereafter, all of which were subject to the Reporting Person's continuous service to the Issuer on each such date.